NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed

NAMS Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
430.71340.45467.7360.387.86
Cash & Short-Term Investments
430.71340.45467.7360.387.86
Cash Growth
2.88%-27.21%674.64%668.09%-
Other Receivables
5.411.882.074.88-
Receivables
5.411.882.074.88-
Prepaid Expenses
9.244.468.181.71.36
Total Current Assets
445.35346.79477.9866.969.22
Property, Plant & Equipment
0.790.10.150.220.01
Other Intangible Assets
0.540.170.21--
Other Long-Term Assets
0.010.040.16--
Total Assets
446.69347.1478.567.999.23
Accounts Payable
5.2816.9211.857.070.4
Accrued Expenses
10.1911.46.124.10.76
Short-Term Debt
----11.65
Current Portion of Leases
0.230.060.070.06-
Current Unearned Revenue
6.068.9413.87--
Other Current Liabilities
23.5512.574.15--
Total Current Liabilities
45.3149.936.0611.2412.81
Long-Term Leases
0.33-0.060.13-
Long-Term Unearned Revenue
0.221.024.79--
Other Long-Term Liabilities
13.397.797.52--
Total Liabilities
59.2558.748.4311.3612.81
Common Stock
11.1510.1710.060.130.05
Additional Paid-In Capital
821.61590.77555.6395.262.45
Retained Earnings
-449.75-316.97-140.04-39.44-6.08
Comprehensive Income & Other
4.424.424.420.67-
Shareholders' Equity
387.44288.39430.0756.63-3.58
Total Liabilities & Equity
446.69347.1478.567.999.23
Total Debt
0.560.060.130.1911.65
Net Cash (Debt)
430.15340.39467.660.19-3.79
Net Cash Growth
2.77%-27.21%676.83%--
Net Cash Per Share
4.944.1424.655.48-0.76
Filing Date Shares Outstanding
90.0289.2781.7711.335
Total Common Shares Outstanding
90.0282.4781.5611.335
Working Capital
400.05296.89441.9255.72-3.59
Book Value Per Share
4.303.505.275.00-0.72
Tangible Book Value
386.9288.22429.8656.63-3.58
Tangible Book Value Per Share
4.303.495.275.00-0.72
Machinery
---0.040.01
Source: S&P Capital IQ. Standard template. Financial Sources.